Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JPS6152151B2 - - Google Patents
[go: Go Back, main page]

JPS6152151B2 - - Google Patents

Info

Publication number
JPS6152151B2
JPS6152151B2 JP7706084A JP7706084A JPS6152151B2 JP S6152151 B2 JPS6152151 B2 JP S6152151B2 JP 7706084 A JP7706084 A JP 7706084A JP 7706084 A JP7706084 A JP 7706084A JP S6152151 B2 JPS6152151 B2 JP S6152151B2
Authority
JP
Japan
Prior art keywords
vef
ferulic acid
tocopherol
benzene
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP7706084A
Other languages
Japanese (ja)
Other versions
JPS60222476A (en
Inventor
Yoshihiro Chikamatsu
Yutaka Ando
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ichimaru Pharcos Co Ltd
Original Assignee
Ichimaru Pharcos Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ichimaru Pharcos Co Ltd filed Critical Ichimaru Pharcos Co Ltd
Priority to JP7706084A priority Critical patent/JPS60222476A/en
Publication of JPS60222476A publication Critical patent/JPS60222476A/en
Publication of JPS6152151B2 publication Critical patent/JPS6152151B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Pyrane Compounds (AREA)

Description

【発明の詳細な説明】[Detailed description of the invention]

本発明は、ビタミンE(トコフエロール)にフ
エルラ酸を反応させて得られる、新規ビタミン
E・フエルラ酸エステル(以下、便宜上、VEF
と呼ぶ)に関する。 VEFは、油脂類(脂質)に対する抗酸化作用
を有し、とくに加温下の油脂類に対する抗酸化作
用に優れた効果を示すものである。 以下にVEFについて、実施例及びその実験結
果を示し、具体的に述べる。 実施例 1 製造法: dl−α−トコフエロール75g、フエルラ酸48g
を、ジメチルホルムアミド300ml、ピリジン150ml
の混液に溶解し、還流冷却器を付けた撹拌機中に
入れ、撹拌下でジケテン30mlを除々に加える。反
応系は、反応熱により上昇するも、更に水浴を用
いて70〜75℃の温度に保ち、2時間反応させる。
次いで反応物を冷却してから、5の水中に注加
し、ベンゼン2.5を加えて、ベンゼン層部に移
行した、反応物(エステル)を抽出する。抽出に
は、ベンゼン層部を、1N塩酸2、1N炭酸水素
ナトリウム2で洗浄後、数回適量の水で洗浄し
た後、窒素気流下で真空濃縮して、VEFを得
る。 実施例 2 製造法: フエルラ酸20gを、300mlの三角フラスコにと
り、ジメチルホルムアミド10mlを加えて、溶解さ
せた後、塩化チオニル50gを加えて、撹拌下に1
時間還流させた後、塩化チオニルを減圧で除き、
ベンゼン適量で洗浄し、濾過して、沈澱物を乾燥
状態で得る。ここに得られたフエルラ酸クロライ
ド塩酸塩を、1のコルベンにとり、ピリジン40
ml、ベンゼン200mlを加えて、これに、dl−α−
トコフエロール40gを、ベンゼン100mlに溶解し
たものを加えて、2時間還流する。還流後は冷却
して濾過を行い、濾液をとり、窒素気流下で真空
濃縮して、VEFを得る。 上記した実施例1〜2で得られたVEFの収量
は、実施例1では、80〜90gと、収率良好にして
得られる。一方、実施例2では、40〜50gが得ら
れる。 〔実験結果〕 上記した実施例で示す方法により得られた
VEFは、第1図に示すUV吸収を有し、赤外吸収
スペクトルは、第2図のごとくの特徴を有してい
る。VEFの作用(効果)は、その抗酸化作用に
あり、これを例えばリノール酸に対する効果につ
いてみると、第1表に示すごとくとなり、VEF
は、dl−α−トコフエロールと同様にして、リノ
ール酸の過酸化物価の上昇を抑制し、とくに45℃
の恒温槽中においては、VEFが非常に優れた抗
酸化作用を示すことがわかつた。
The present invention relates to a novel vitamin E ferulic acid ester (hereinafter referred to as VEF for convenience) obtained by reacting vitamin E (tocopherol) with ferulic acid.
). VEF has an antioxidant effect on fats and oils (lipids), and exhibits particularly excellent antioxidant effects on fats and oils under heating. Examples and experimental results of VEF will be shown and specifically described below. Example 1 Production method: 75 g of dl-α-tocopherol, 48 g of ferulic acid
, 300ml of dimethylformamide, 150ml of pyridine
Dissolve in a mixture of , put into a stirrer equipped with a reflux condenser, and gradually add 30 ml of diketene while stirring. Although the temperature of the reaction system increases due to the heat of reaction, the temperature is further maintained at 70 to 75°C using a water bath, and the reaction is continued for 2 hours.
Next, the reactant was cooled, and then poured into the water in Step 5, and 2.5 g of benzene was added to extract the reactant (ester) that had migrated to the benzene layer. For extraction, the benzene layer is washed with 2 portions of 1N hydrochloric acid and 2 portions of 1N sodium bicarbonate, washed several times with an appropriate amount of water, and then concentrated in vacuo under a nitrogen stream to obtain VEF. Example 2 Production method: 20 g of ferulic acid was placed in a 300 ml Erlenmeyer flask, 10 ml of dimethylformamide was added to dissolve it, 50 g of thionyl chloride was added, and the mixture was dissolved under stirring for 1 hour.
After refluxing for an hour, thionyl chloride was removed under reduced pressure.
Wash with appropriate amount of benzene and filter to obtain a precipitate in dry form. The obtained ferulic acid chloride hydrochloride was added to 40 ml of pyridine.
ml, add 200ml of benzene, and add dl−α−
Add 40 g of tocopherol dissolved in 100 ml of benzene and reflux for 2 hours. After refluxing, the mixture is cooled and filtered, and the filtrate is collected and concentrated in vacuo under a nitrogen stream to obtain VEF. The yield of VEF obtained in Examples 1 and 2 described above is 80 to 90 g in Example 1, which is a good yield. On the other hand, in Example 2, 40 to 50 g is obtained. [Experimental results] Obtained by the method shown in the above example
VEF has the UV absorption shown in FIG. 1, and the infrared absorption spectrum has the characteristics shown in FIG. The action (effect) of VEF lies in its antioxidant action, and looking at its effect on linoleic acid, for example, it is as shown in Table 1, and VEF
Similar to dl-α-tocopherol, it suppresses the increase in the peroxide value of linoleic acid, especially at 45°C.
It was found that VEF exhibited excellent antioxidant activity in a constant temperature bath.

〔安全性〕〔safety〕

VEFの急性毒性試験は、体重30g前後の雌性
dd系マウスを用い、4000mg/Kgの経口投与と8000
mg/Kgの経口投与の二群(一群3匹)で実施した
が、死亡例、中毒症状の発現は認められなかつ
た。したがつて、VEFの急性LD50値は、8000
mg/Kg以上と推定された。 〔用途又は応用(利用)分野〕 VEFは、各種油脂類及び油脂類を含有する食
品類、化粧品、医薬品、飼料等の抗酸化剤として
用いることが可能であると共に、ビタミンEの有
する効果が期待される。つまり、スタート物質と
して用いられるビタミンEは、抗不妊ビタミンの
一つとて発見されて以来、その後の研究により、
生体内の脂質の過酸化物の生成を抑制し、生体膜
の安定化に働き、生殖腺機能を賦活させ、さらに
末梢血管の拡張作用、サクシニツクオキシダーゼ
などの酵素に作用して、物質代謝に好影響を与
え、これによつて、動脈硬化、糖尿病、更年期障
害など、成人病の予防と治療に繁用されるに至つ
ている。一方、フエルラ酸は、植物中に含まれる
一成分として、とくに穀類中に含有している。 フエルラ酸は、抗酸化作用があると共に、その
経口投与は、それによつて胆汁分泌の促進作用が
知られている。 したがつて、VEFの応用分野は、体内に吸収
されたのち、ビタミンEとフエルラ酸の有する両
作用を発揮し、とくに胆汁分泌を促進して、胆石
や肝障害を防ぐことが期待される。又、化粧品類
や食品類、飼料等への配合は、その加工(製剤
化)上、加熱条件がともなうが、このような場合
には、処方中の油脂類は、その製品化された後
に、急速に過酸化物価が高まることが多い。とく
に夏場の高温、多湿条件下では、製品に対する影
響も強くなり、その結果は油脂特有の酸敗臭も強
く現われるが、VEFを添加した場合では、これ
らの影響を防ぐことが出来る。
The VEF acute toxicity test was conducted on females weighing around 30g.
Oral administration of 4000mg/Kg and 8000mg/Kg using DD mice.
The experiment was conducted in two groups (3 animals per group) with oral administration of mg/Kg, but no deaths or symptoms of toxicity were observed. Therefore, the acute LD50 value of VEF is 8000
It was estimated to be more than mg/Kg. [Applications or fields of application] VEF can be used as an antioxidant in various oils and fats and foods containing oils and fats, cosmetics, medicines, feeds, etc., and is expected to have the effects of vitamin E. be done. In other words, since vitamin E, which is used as a starting material, was discovered as an anti-infertility vitamin, subsequent research has shown that
It suppresses the production of lipid peroxides in the living body, works to stabilize biological membranes, activates gonadal function, dilates peripheral blood vessels, acts on enzymes such as succinic oxidase, and favors material metabolism. As a result, it has come to be frequently used in the prevention and treatment of adult diseases such as arteriosclerosis, diabetes, and menopausal disorders. On the other hand, ferulic acid is a component contained in plants, particularly in grains. Ferulic acid has an antioxidant effect, and oral administration thereof is known to promote bile secretion. Therefore, the field of application of VEF is expected to be that after being absorbed into the body, it exerts the dual effects of vitamin E and ferulic acid, and in particular promotes bile secretion and prevents gallstones and liver damage. In addition, when blended into cosmetics, foods, feeds, etc., heating conditions are required during processing (formulation), but in such cases, the oils and fats in the formulation are Peroxide values often increase rapidly. Especially under high temperature and high humidity conditions in the summer, the effects on the product become stronger, resulting in the strong rancid odor characteristic of fats and oils, but when VEF is added, these effects can be prevented.

【図面の簡単な説明】[Brief explanation of the drawing]

第1図は、VEFの有する紫外部吸収スペクト
ルである。Aはdl−α−トコフエロール、Bは、
VEFである。第2図は、VEFの赤外線吸収スペ
クトルである。
FIG. 1 shows the ultraviolet absorption spectrum of VEF. A is dl-α-tocopherol, B is
It is VEF. Figure 2 shows the infrared absorption spectrum of VEF.

Claims (1)

【特許請求の範囲】 1 dl−α−トコフエロールとフエルラ酸を、ジ
メチルホルムアルドとピリジンからなる混合溶媒
中に溶解し、環流冷却器を付けた撹拌器中に入
れ、撹拌下でジケテンを徐々に加え、その撹拌器
中の温度を、70〜75℃に保ちながら反応させ、反
応後、水中に入れ、さらに、ベンゼンを加えて、
反応物をベンゼン層部に移行させて分取し、洗浄
後、窒素気流下で、真空濃縮を行う工程からなる
ことを特徴とする、一般式〔1〕で示される、ト
コフエロール・フエルラ酸エステルの製造法。
[Claims] 1. dl-α-tocopherol and ferulic acid are dissolved in a mixed solvent consisting of dimethyl formalde and pyridine, placed in a stirrer equipped with a reflux condenser, and diketene is gradually dissolved under stirring. Then, the temperature in the stirrer was maintained at 70 to 75°C and the mixture was reacted. After the reaction, the mixture was poured into water, and then benzene was added.
A method of tocopherol ferulic acid ester represented by the general formula [1], which comprises the steps of transferring the reactant to a benzene layer, separating it, washing it, and concentrating it in vacuum under a nitrogen stream. Manufacturing method.
JP7706084A 1984-04-17 1984-04-17 Tocopherol ferulate Granted JPS60222476A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP7706084A JPS60222476A (en) 1984-04-17 1984-04-17 Tocopherol ferulate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7706084A JPS60222476A (en) 1984-04-17 1984-04-17 Tocopherol ferulate

Publications (2)

Publication Number Publication Date
JPS60222476A JPS60222476A (en) 1985-11-07
JPS6152151B2 true JPS6152151B2 (en) 1986-11-12

Family

ID=13623246

Family Applications (1)

Application Number Title Priority Date Filing Date
JP7706084A Granted JPS60222476A (en) 1984-04-17 1984-04-17 Tocopherol ferulate

Country Status (1)

Country Link
JP (1) JPS60222476A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002284625A (en) * 2001-03-23 2002-10-03 Nippon Hypox Lab Inc Cosmetics

Also Published As

Publication number Publication date
JPS60222476A (en) 1985-11-07

Similar Documents

Publication Publication Date Title
US10981854B2 (en) Method for purification of 4-hydroxyacetophenone
EP0703954A1 (en) Polyphenol derivative compositions and preparation thereof
JP2007259866A (en) Production and use of phosphatide
MC1358A1 (en) STEAM GENERATOR DEVICE FOR BOREHOLE
WO2009062662A1 (en) Pharmaceutical and nutraceutical compositions based on menaquinols
JPS6152151B2 (en)
JPH0432073B2 (en)
JPH05255367A (en) Production of cantharidin derivative composition and anti-viral agents containing it
JPS6388159A (en) Production of docosahexaenoic acid ester
US4025631A (en) Dihydroquinoline derivatives of antioxidant activity
US4046765A (en) Dihydroquinoline derivatives of antioxidant activity and a process for the preparation thereof
JPS621396B2 (en)
JPS5940179B2 (en) Antioxidant
CA2628304C (en) Method of refining episesamin
LU84429A1 (en) AS DRUGS, CERTAIN DERIVATIVES OF 4-PHENYL 4-OXO 2-BUTENOIC ACID AND COMPOSITIONS CONTAINING THEM
JPH10306032A (en) Energy enhancer
US2912360A (en) Process for obtaining intrinsic factor
RU2141334C1 (en) Method of preparing agent "olipifat" for treatment of patients with nononcological pathology in body
RU2163816C1 (en) Method of preparing agent for treatment of non-oncological pathology of body
US4146728A (en) Esters of 2-[4-(4-chlorobenzoyl)-phenoxy-2-methyl-propionic acid with bis-(hydroxyalkylthio)-alkanes
RU2178303C1 (en) Antioxidant and antiradical agent
JPH02503792A (en) Pharmaceutical composition for treating adrenoleukodystrophy
CA1072969A (en) Hypolipidemic p-aminobenzoic acids
BE875451A (en) NEW MEDICINES CONSTITUTED BY P-AMINO-BENZOIC ACID DERIVATIVES
CN118239995A (en) Ferulic acid glucose conjugate, and preparation method, application and derivative thereof